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ORIGINAL CLINICAL REPORT

Ventilation Strategies During Extracorporeal
Membrane Oxygenation for Neonatal
Respiratory Failure: Current Approaches
Among Level IV Neonatal ICUs
OBJECTIVES: To describe ventilation strategies used during extracorporeal
membrane oxygenation (ECMO) for neonatal respiratory failure among level IV
neonatal ICUs (NICUs).
DESIGN: Cross-sectional electronic survey.
SETTING: Email-based Research Electronic Data Capture survey.

John Ibrahim, MD1
Burhan Mahmood, MD1
Robert DiGeronimo, MD2
Natalie E. Rintoul, MD3
Shannon E. Hamrick, MD4
Rachel Chapman, MD5

PATIENTS: Neonates undergoing ECMO for respiratory failure at level IV NICUs.

Sarah Keene, MD4

INTERVENTIONS: A 40-question survey was sent to site sponsors of regional
referral neonatal ECMO centers participating in the Children’s Hospitals Neonatal
Consortium. Reminder emails were sent at 2- and 4-week intervals.

Ruth B. Seabrook, MD6

MEASUREMENTS AND MAIN RESULTS: Twenty ECMO centers responded
to the survey. Most primarily use venoarterial ECMO (65%); this percentage is
higher (90%) for congenital diaphragmatic hernia. Sixty-five percent reported following protocol-based guidelines, with neonatologists primarily responsible for
ventilator management (80%). The primary mode of ventilation was pressure control (90%), with synchronized intermittent mechanical ventilation (SIMV) comprising 80%. Common settings included peak inspiratory pressure (PIP) of 16–20 cm
H2O (55%), positive end-expiratory pressure (PEEP) of 9–10 cm H2O (40%),
I-time 0.5 seconds (55%), rate of 10–15 (60%), and Fio2 22–30% (65%). A
minority of sites use high-frequency ventilation (HFV) as the primary mode (5%).
During ECMO, 55% of sites target some degree of lung aeration to avoid complete atelectasis. Fifty-five percent discontinue inhaled nitric oxide (iNO) during
ECMO, while 60% use iNO when trialing off ECMO. Nonventilator practices
to facilitate decannulation include bronchoscopy (50%), exogenous surfactant
(25%), and noninhaled pulmonary vasodilators (50%). Common ventilator thresholds for decannulation include PEEP of 6–7 (45%), PIP of 21–25 (55%), and
tidal volume 5–5.9 mL/kg (50%).

John Daniel, MD8

CONCLUSIONS: The majority of level IV NICUs follow internal protocols for ventilator management during neonatal respiratory ECMO, and neonatologists primarily direct management in the NICU. While most centers use pressure-controlled
SIMV, there is considerable variability in the range of settings used, with few centers using HFV primarily. Future studies should focus on identifying respiratory
management practices that improve outcomes for neonatal ECMO patients.
KEY WORDS: extracorporeal membrane oxygenation; neonate; respiratory
failure; ventilation; ventilator

E

xtracorporeal membrane oxygenation (ECMO) continues to be a lifesaving therapy for neonates with severe refractory cardiorespiratory failure
since its first successful reported application in 1975 (1). Respiratory
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KEY POINTS
• Question: The goal of this study was to understand and describe the scope of ventilator management strategies during neonatal respiratory
extracorporeal membrane oxygenation (ECMO)
among high-volume neonatal ECMO centers
participating in the Children’s Hospitals Neonatal
Consortium (CHNC).
• Findings: This is a report of an electronic
survey of U.S. neonatal ECMO centers participating in the CHNC. Despite several aspects of neonatal ventilator management during ECMO that
appear to be common among a majority of centers, a universal understanding of ideal “lung rest”
remains elusive, and there remains a diversity of
ventilator management strategies with apparently
conflicting priorities.
• Meaning: Additional research is needed to
correlate individual clinical practice strategies with
pulmonary outcomes toward the goal of identifying and recommending best practices for ventilator management during neonatal ECMO for
respiratory failure.

failure remains the most common indication for neonatal ECMO, with an overall survival rate to discharge or transfer of 69% (Extracorporeal Life Support
Organization [ELSO] report, April 2021) (2). Common
indications include congenital diaphragmatic hernia
(CDH), meconium aspiration syndrome, and persistent pulmonary hypertension, together accounting for
almost 75% of all neonatal ECMO runs.
Worldwide, there has been a proliferation of ECMO
centers over the past decade, primarily due to the
increasing use of this therapy for adult respiratory
failure, whereas the number of neonatal and pediatric
cases has remained relatively stagnant (2). From 2016
to the present, the average patient volume per center
for neonatal and pediatric patients has been 10 cases
per year for combined cardiorespiratory failure (2).
Because of increased regionalization, many neonatologists routinely refer ECMO candidates to regional
children’s hospitals and have lost currency in neonatal
ECMO management.

2     www.ccejournal.org

The ELSO recently published guidelines for neonatal respiratory failure that include recommendations
for ventilator management on ECMO (3). ELSO recommends initiating lung rest ventilator settings once a
patient has transitioned to venoarterial or venovenous
support to mitigate ongoing lung injury, utilizing limited peak pressure and low rate. ELSO guidelines, however, are nonspecific regarding the amount of positive
end-expiratory pressure (PEEP) that should be provided, as there is limited evidence in neonates regarding
optimal PEEP during ECMO. Historically, the use of a
high versus low PEEP strategy has been debated, along
with the optimal degree of lung inflation that should
be targeted to minimize ventilator-induced lung injury (VILI). Additionally, some centers have preferred
to use high-frequency ventilation (HFV) over conventional ventilation to theoretically provide more
efficacious lung rest. Keszler et al (4) published a multicenter randomized trial in the early 1990s comparing
a high to low PEEP strategy in neonates on venoarterial ECMO and showed that a higher PEEP approach
was associated with reduced ECMO duration, fewer
complications, and better short-term lung compliance
but with similar survival.
Adherence of individual centers and providers to the
published ELSO guidelines regarding ventilator management for neonates with respiratory failure remains
unclear. Alapati et al (5) published data collected from
the ELSO registry from 2008 to 2013, reporting rest
ventilator settings recorded at 24 hours after neonatal
ECMO initiation. The authors found wide variation
in the ventilatory support used for lung rest as well
as mixed outcomes depending on the PEEP strategy
used. The data from this article are now more than a
decade old, and it is unclear how more recent trends
in regionalized neonatal ECMO care and advances in
ventilator and ECMO technology may impact these
practices.
The primary objective of this study was to understand the spectrum of ventilation management strategies used for neonates with respiratory failure on
ECMO among busy referral ECMO centers, as well as
to better clarify the role of neonatologists in this care.
Aligning with the above-mentioned objective, we conducted a multicenter survey among a subset of large
regional level IV neonatal ICUs (NICUs) in children’s
hospitals that provide neonatal ECMO.
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METHODS
Data Source
The Children’s Hospitals Neonatal Consortium
(CHNC) is a multicenter collaborative of level IV
NICUs in children’s hospitals in the United States
and Canada dedicated to developing quality and research initiatives across participating institutions.
Participating NICUs have more than 400 annual admissions or more than 25 NICU beds and more than 50%
of infants outborn. Data are collected prospectively in
the Children’s Hospitals Neonatal Database (CHND)
and used to study clinical outcomes and resource utilization of a unique population of medically complex
infants. For this study, the survey was sent to 33 members of the CHNC who perform neonatal ECMO and
are actively involved with the CHNC ECMO Focus
Group. The Institutional Review Board (IRB) at each
participating institution approved participation in
CHND and associated research studies, including ethical clearance in the use of de-identified database data
(6). Specifically, the primary survey author’s center
participation was approved on January 8, 2010, by the
Nemours Delaware IRB, Nemours Office of Human
Subjects Protection (No. 149542-1). The procedures
followed were in accordance with the ethical standards
of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as
most recently amended. Survey participants provided
informed consent for the use of their responses in the
reporting of this study.
Study Design
We conducted a cross-sectional survey of site sponsors
at CHNC-participating ECMO centers. The survey
was created, and study data were collected using
Research Electronic Data Capture (REDCap) hosted at
Children’s Hospital of Philadelphia (7, 8). REDCap is a
secure, web-based software platform designed to capture data for research studies.
Survey Development
The survey was developed by the study investigators,
who are members of the CHNC ECMO Focus Group,
a collaborative of neonatologists and pediatric surgeons from CHNC-participating NICUs with interest
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and expertise in neonatal ECMO aiming to benchmark
and improve neonatal ECMO outcomes. Survey questions underwent several iterations for content, clarity,
and understandability based on feedback from members of the focus group. The final survey contained 40
targeted questions with subcategories (Supplemental
Table 1, http://links.lww.com/CCX/B75).
Survey Distribution
The survey was distributed to CHNC site sponsors by
email via the organizational listserve initially in June
2019 and again in July 2019 with all responses finalized
by August 2019. The email contained a link to the online survey, which collected data in REDCap.
Statistical Analysis
We conducted data analysis using descriptive statistics
and percentages of respondents.

RESULTS
We received responses from 20 of the 33 CHNC level
IV NICUs involved with the focus group (61% response rate). Eight of the respondents (40%) were
high-volume centers with more than 10 neonatal respiratory ECMO runs per year. Venoarterial ECMO
(13 centers, 65%) was more commonly identified as
the primary mode for neonatal ECMO compared
with venovenous ECMO (seven centers, 35%). In
contrast, for patients with CDH, most reported
using venoarterial ECMO (18 centers, 90%). Fifty
percent of hospitals reported that they had dedicated
ECMO teams in addition to the primary ICU team.
In 70% of these centers, ventilator management was
directed by the ECMO team. Neonatologists either
on the ECMO team or as part of the ICU team managed ventilator settings at 16 centers (80%), while at
other sites, pediatric intensivists, cardiac intensivists, or pediatric surgeons were primarily responsible
(Table 1). At 15 centers (75%), neonatal ECMO for
respiratory failure is performed in the NICU, while
two centers (10%) reported managing neonatal
ECMO in the PICU. Of interest, one center shares
NICU and PICU space, and two centers reported
using multiple different units, including the NICU,
PICU, and/or cardiac ICU.

www.ccejournal.org
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TABLE 1.

Background of the Physicians Managing
the Ventilator During Neonatal
Extracorporeal Membrane Oxygenation
Physician Specialty
Neonatologist

No. of Centers
(%)
16 (80)

TABLE 2.

Modes of Ventilation Used During
Neonatal Respiratory Extracorporeal
Membrane Oxygenation
Modes of Ventilation

No. of Centers (%)

High-frequency oscillatory ventilation

14 (70)

High-frequency jet ventilation

3 (15)
1 (5)

Pediatric intensivist

5 (25)

Cardiac intensivist

2 (10)

High-frequency percussive ventilation
(e.g., VDR, bronchotron, TXP)

Pediatric surgeon

4 (20)

SIMV, pressure control

17 (85)

Cardiac surgeon

None

SIMV, volume targeted

7 (35)

Other

None

AC, pressure control

3 (15)

Ventilator Strategies During Neonatal ECMO
The majority of respondents (13 centers, 65%) use a
standardized protocol to target initial ventilator settings and then adjust management based on chest radiograph findings and the underlying disease process
throughout the ECMO run. Five centers (25%) use an
initial individualized case approach based on the underlying disease, chest radiograph findings, or both,
while only two centers leave ventilator management to
the on-service attending’s discretion. While some variability exists regarding the primary mode of ventilation, several modes of ventilation were employed by
different centers during the ECMO run with the majority (17 centers, 85%) using synchronized intermittent mechanical ventilation (SIMV) pressure control,
seven centers (35%) using volume-targeted SIMV, six
centers (30%) using pressure-regulated volume control, three centers (15%) using assist-control pressure
control, and three centers (15%) using airway pressure release ventilation (APRV) (Table 2). Neurally
adjusted ventilatory assist (NAVA) use was reported
by only one center. Of interest, three centers (15%)
reported extubation as a ventilation strategy while on
ECMO for select patients.
In regard to the specific conventional ventilation
settings used (Table 3), the majority (14 centers, 70%)
targeted a PEEP of 7 cm H2O or greater, although only
one center reported using a PEEP of more than 10. The
most commonly reported peak inspiratory pressure
(PIP) range was 16–20 (11 centers, 55%). Among the
50% of centers reporting a specific tidal volume target,
the most common range (35%) was 5–6 mL/kg. Eleven
centers (55%) used an inspiratory time of 0.5 seconds.
4     www.ccejournal.org

AC, volume targeted

None

Pressure-regulated volume control

6 (30)

Airway pressure release ventilation

3 (15)

Neurally adjusted ventilatory assist

1 (5)

Extubation

3 (15)

AC = assist control, SIMV = synchronized intermittent mandatory
ventilation, VDR = Volume Diffusive Respirator.

The majority (16 centers, 80%) used ventilator rates of
less than 20 beats/min, with none using rates of more
than 25 beats/min. Most centers (15, 75%) maintain
ventilator Fio2 between 0.21 and 0.30 and five centers
(25%) between 0.31 and 0.40.
Only one center (5%) identified HFV (high-frequency oscillatory ventilation [HFOV], high-frequency jet ventilation, or flow interrupter) as the
preferred mode of ventilation for neonates on ECMO.
Overall, the majority of centers (14, 70%) reported
utilizing HFV for selected indications but not as the
primary modality (Table 2). Air leak was stated as the
most common indication for HFV (10 centers, 50%).
For HFOV specifically, three sites reported an individualized approach to setting mean airway pressure
(MAP) based on the underlying lung disease. Three
centers reported using MAPs of 10–11 cm H2O, while
four centers reported a higher MAP of 12–13. For amplitude, three centers reported a range of 21–26, with
only one center each reporting ranges of 10–15, 16–20,
and 26–30. Seven centers use an initial high-frequency
rate between 7 and 10 Hz, while three centers prefer a
higher frequency between 11 and 14 Hz.
The majority of centers discontinue inhaled nitric
oxide (iNO) administration during ECMO (11 centers,
55%), while nine centers (45%) selectively continue
November 2022 • Volume 4 • Number 11
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TABLE 3.

Conventional Mechanical Ventilation
Rest Settings at Extracorporeal
Membrane Oxygenation Initiation
Ventilator Setting

No. of Centers (%)

Positive end-expiratory pressure (cm H2O)
5–6

6 (30)

7–8

5 (25)

9–10

8 (40)

11–12

1 (5)

Peak inspiratory pressure (cm H2O)
12–15

2 (10)

16–20

11(55)

21–25

6 (30)

Inspiratory time (s)
< 0.5
0.5
1

6 (30)
11 (55)
3 (15)

Rate (beats/min)
10–15

12 (60)

16–20

4 (20)

21–25

4 (20)

Tidal volume (mL/kg)
3–4

3 (15)

5–6

7 (35)

No criteria

10 (50)

iNO. Among those discontinuing iNO routinely, six
centers wean off over 24 hours, while five discontinue
it immediately.
Lung Recruitment and Decannulation
Thresholds
All respondents agreed that some extent of lung derecruitment is typically expected following cannulation and weaning of ventilatory support. However,
most respondents (11 centers, 55%) consider whiteout (or complete lung opacification) on chest radiograph unacceptable. Four centers (20%) reported that
they would accept complete lung de-recruitment, and
two others (10%) specified that the degree of lung inflation on chest radiograph would not alter their protocol-defined ventilator settings.
Many centers use a variety of active lung recruitment maneuvers during ECMO. These include hand
Critical Care Explorations

ventilation (10 centers, 50%), chest physiotherapy (10
centers, 50%), bronchoscopy (11 centers, 55%), change
of ventilator mode (10 centers; 50%), alteration in ventilator settings (16 centers, 80%), and administration
of exogenous surfactant (five centers, 25%). Six centers
reported “other” maneuvers without further specification. Five centers (20%) reported that they did not use
active recruitment measures, allowing spontaneous
lung recruitment while maintaining ventilator rest
settings. For bronchoscopy specifically, 50% of sites
reported it is not a routine practice, while the other
50% noted they would consider bronchoscopy prior to
decannulation on an individual basis.
The most commonly accepted PEEP for decannulation (nine centers; 45%) was 6–7 cm H2O, while
four centers (20%) did not have specific criteria. Four
centers (20%) use a higher PEEP threshold of 8–10,
while three centers (15%) require a lower PEEP of
5–6. The majority of responding centers (11 centers,
55%) were comfortable coming off ECMO with a PIP
of 21–25 cm H2O, while only three centers (15%) typically tolerate 26–30. The remainder did not report a
specific limit. For centers that use tidal volume targets,
5–5.9 mL/kg was most commonly identified as an acceptable threshold for decannulation (nine centers,
45%) (Table 4). For HFOV, 50% of centers reported
no specific MAP as a threshold for decannulation. Of
those reporting MAP targets, six centers (30%) accept
14–15 cm H2O and three (15%) a MAP of 10–13.
Ten centers (50%) reported they often use iNO to
help transition off ECMO, while eight respondents
(40%) rarely use iNO for this purpose. Other noninhaled pulmonary vasodilators (e.g., epoprostenol,
treprostinil, sildenafil, and milrinone) are occasionally
and selectively used by up to 50% of centers.

DISCUSSION
We conducted a survey of CHNC neonatal ECMO centers to assess variations in ventilation strategies across
different level IV NICUs during neonatal ECMO for
respiratory failure. The majority of responding centers
implemented a standardized protocol to target initial
ventilator lung rest settings, although this was further
adjusted based on chest radiograph findings and the
underlying disease, reflecting a flexible approach that
adapts as lung disease evolves. While neonatologists
may be less involved in extracorporeal life support
(ECLS) outside of regional referral NICUs, our survey
www.ccejournal.org
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TABLE 4.

Acceptable Conventional Ventilator
Decannulation Thresholds
Ventilator Threshold Settings

No. of Centers (%)

Positive end-expiratory pressure (cm H2O)
3–5

3 (15)

6–7

9 (45)

8–10

4 (20)

No criteria

4 (20)

Peak inspiratory pressure (cm H2O)
< 20

2 (10)

21–25

11 (55)

26–30

3 (15)

Tidal volume (mL/kg)
4–5

2(10)

5–6

9 (45)

6–7

2 (10)

No criteria

7 (35)

indicates that, within level IV neonatal ECMO centers, respiratory care during ECMO remains primarily
managed by neonatologists. SIMV pressure control remains the most common initial ventilation mode used.
However, wide variability remains regarding specific
ventilator settings used. HFV, while not the preferred
primary ventilatory mode, is used by the majority of
centers during ECMO for specific indications. The
results of our survey further fortify the necessity for
more rigorous research in the field of lung ventilation
strategies and recruitment during neonatal ECMO.
Since its first neonatal use more than 40 years ago
(1), ECMO has been shown to improve survival in late
preterm and term infants with severe cardiorespiratory failure, pulmonary hypertension, and hypoxemia
refractory to conventional therapies. By temporarily
supporting cardiorespiratory function, ECMO serves
as a bridge to allow organs, particularly the lungs, time
to recover (9). The optimal ventilation strategy to provide “lung rest” on neonatal respiratory ECMO remains unclear and an area of speculation, while there
remains a paucity of evidence-based literature to guide
therapy.
Before ECMO is initiated, exposure to high ventilator settings and free radicals from 100% oxygen can
worsen lung injury in neonates with respiratory failure.
6     www.ccejournal.org

Mechanisms of injury include volutrauma from alveolar overdistension, barotrauma from high ventilator
pressures, atelectotrauma from alveolar collapse, and
biotrauma from inflammation (10–12). There may also
be an inherent genetic susceptibility to increased inflammation in some patients, contributing to further
damage (10). The pathophysiology of VILI includes
increased alveolar permeability with pulmonary edema,
cellular destruction with disordered repair, diffuse alveolar damage, accumulation of proteinaceous alveolar
fluid with neutrophil influx, surfactant dysfunction
with patchy areas of alveolar collapse, deposition of hyaline membranes, and formation of microthrombi (13,
14). Furthermore, following ECMO initiation, diffuse
atelectasis induced by lower mechanical ventilation,
together with pulmonary inflammation and complement activation following blood contact with foreign
surfaces of the ECMO circuit, can contribute to pulmonary opacification (15, 16).
An approach that decreases peak pressures, avoids
excessive tidal volumes, and optimizes PEEP to prevent alveolar collapse could minimize additional lung
injury and promote healing, shorten time on bypass,
potentially reduce ventilator days post-ECMO, and
possibly improve pulmonary outcomes.
An international survey of ventilation management
strategies for venovenous ECMO conducted across 141
ELSO-registered centers reported almost a third utilizing an established mechanical ventilation protocol
(17). Of the neonatal/pediatric centers evaluated, most
used pressure-control mode for lung rest. The majority
of centers surveyed targeted a tidal volume of 6 mL/
kg or less and PEEP of 6–10 cm H2O while on venovenous support. Similarly, a large retrospective analysis of ELSO registry data (2008–2013) also reported
common utilization of conventional mechanical ventilation for lung rest during neonatal respiratory ECMO
(5). Alapati et al (5) compared outcomes based on
PEEP levels at 24 hours after ECMO initiation (low
PEEP 4–6, mid-level PEEP 7–9, or high PEEP 10–12).
There was no difference in survival among the three
groups. Infants in the high-PEEP group required the
shortest mean duration of ECMO but had an increased
duration of mechanical ventilation after decannulation
compared with the low-PEEP group.
Our study showed that when on pressure-control
SIMV support, higher PEEP settings are employed
for lung rest by most centers, likely in an attempt
November 2022 • Volume 4 • Number 11
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to maintain some degree of alveolar aeration. This
strategy may reduce atelectasis while improving lung
compliance. However, there may be a subset of patients
whose lungs may remain opacified radiographically
despite higher PEEP settings because of the severity of
the underlying lung disease. With higher PEEP, pulmonary function may also improve earlier, promoting
a shorter time on ECMO support (18). A decrease in
pulmonary vascular leak and alveolar macrophage activation has been reported with the use of higher PEEP
on ventilatory support (19). One must also be mindful
of the damaging effect of very high PEEP on the lungs,
including worsening pulmonary vascular resistance
and the potential for hemodynamic compromise from
impaired venous return, especially in the presence of
underlying inflammation.
The concept of higher PEEP utilization to accelerate
lung recovery was first introduced by Pesenti et al (20),
while the only prospective multicenter randomized
controlled trial comparing low PEEP (3–5 cm H2O)
with high PEEP (12–14 cm H2O) in neonatal ECMO
support was performed more than 30 years ago (4).
This study reported shorter ECMO duration, fewer
complications, improved lung compliance, and less
pulmonary opacification on radiograph in the higher
PEEP group. Interestingly, the evolving practice of
extubating patients and allowing awake spontaneous
breathing during ECLS introduces a contradictory yet
equally successful approach. With extubation comes
the removal of PEEP and the concern for complete
atelectasis. However, limited clinical experience has
shown that, with spontaneous breathing and coughing
to provide airway clearance, patients can self-recruit as
the pulmonary disease process and inflammation resolve. In some cases, intubation and positive airway
pressure are required to initiate lung recruitment. Our
survey revealed that extubation on ECMO remains an
uncommon practice among regional neonatal ECMO
centers (three centers, 15%). But even this represents
an evolving practice compared with the findings of
Marhong et al (17), who reported no neonatal or pediatric centers practiced extubation as recently as 2015. In
addition, Jenks et al (21) reported this practice among
27% of pediatric centers, 42% of mixed, and 52% of
adult centers. The practice of extubating patients on
ECMO for maximal lung protection and encouraging
spontaneous lung recruitment is much more commonplace in the adult ECLS population, with limited
Critical Care Explorations

reported experience in neonates. Although our survey
did not inquire about the reasons for this practice,
there may be a subset of patients (e.g., severe or refractory air leak) who could benefit from this approach
(22, 23). A recent case series of eight neonates electively extubated during neonatal respiratory ECMO
reported effective resolution of lung disease and successful decannulation of all patients (22). The authors
concluded that, besides facilitating the resolution of air
leaks without the risks of chest tube placement, spontaneous breathing alone can often be sufficient to recruit lungs for successful decannulation.
We found that HFV is used on a case-by-case basis,
particularly for patients with air leaks (e.g., pneumothorax). In a previous study (5), only 12% of the
surveyed centers used HFV as the primary mode of
ventilation. That study reported that infants in the HFV
group required a longer duration of ECMO and mechanical ventilation after decannulation. Interestingly,
those patients who were placed on HFV had lower pH,
higher respiratory severity score, higher oxygenation
index, and lower blood pressure before cannulation,
likely reflecting more severe lung disease rather than
any causative effect of the use of HFV.
The type and timing of lung recruitment maneuvers reported by responding centers were mostly individualized based on such factors as underlying disease
process, fluid balance, and signs of lung expansion.
Common recruitment strategies included hand ventilation, chest physiotherapy, change of ventilator mode
and settings, and administration of exogenous surfactant. There was variability in the use of bronchoscopy,
although this procedure was not routinely employed.
Few centers preferred waiting for the lungs to open
spontaneously without any active recruitment measures. This observation was also reported in a previous
study, in which bronchoscopy was used more routinely
by centers managing adult patients or both adult (76%)
and pediatric patients (81%) compared with pediatric
centers (25%) (21). Although the indication for bronchoscopy in the adult population was different, only
25% of the centers used it for atelectasis.
A unique feature of our survey was addressing the
use of iNO and noninhaled pulmonary vasodilators as
adjuvant therapies to facilitate weaning from ECMO.
Nearly half of respondents sometimes continue iNO
through the entire ECMO run, although most (55%)
discontinue iNO following ECMO initiation.
www.ccejournal.org
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Our cross-sectional study has several limitations as
a survey of CHNC level IV NICUs providing neonatal
respiratory ECMO. Our survey response rate of 61%
enables nonresponder bias, as our assessment does not
entirely represent management practices among all the
active CHNC neonatal ECMO centers. Being an observational retrospective study, the possibility exists
for observer and recall bias, as the results may have
been influenced by the experiences and opinions of the
responding individuals. The study was unable to detail
the evolution of ventilator management over time during the ECMO run, nor does it characterize practices
based on underlying disease processes or clinical patient specifics.
We did not assess ventilator strategy variation for
ECMO patients with specific or complex lung diseases,
such as bronchopulmonary dysplasia and CDH, who
may require a different approach for lung rest or alternative management protocols.
In conclusion, our survey shows that, although there
are many commonalities across centers in respiratory
management during neonatal ECMO (Table 5), there
remains a wide variation in practice as well, with no
clear consensus on optimal ventilator strategies. This
significant inter-center variability likely reflects the
paucity of compelling high-quality evidence to drive
standardization of practices. With evolving technology,
newer modes of ventilation like NAVA and APRV are
now available; however, there are currently no studies
or recommendations regarding their use in neonatal
respiratory ECMO. Prospective studies with multicenter collaboration are needed to compare ventilator
management strategies during neonatal respiratory
ECMO, particularly with respect to clinical outcomes.

TABLE 5.

Summary of Common Ventilation Practices
Common Ventilation Practices
Primary mode of ventilation: synchronized intermittent
mechanical ventilation, pressure control
Develop and follow protocolized guidelines of care
Neonatologists most commonly direct ventilator
management
Maintain lung aeration with moderate to high positive
end-expiratory pressure, avoid complete atelectasis
Consider adjunct therapies to recruit lungs when needed to
facilitate decannulation
8     www.ccejournal.org
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